CSIMarket


Rocket Pharmaceuticals Inc   (RCKT)
Other Ticker:  
 


 

Rocket Pharmaceuticals Inc

RCKT's Financial Statements and Analysis



Rocket Pharmaceuticals Inc increased III. Quarter net loss per share of $-0.87 compare to net loss per share of $-0.79 recorded in the same quarter a year ago a decrease compare to $-0.83 realized in previous quarter.


III. Quarter
Earnings Per Share Revenues
$ -0.87 $  0 Mill
$-0.08     Unch.    



Rocket Pharmaceuticals Inc 's Revenue fell by 0 % in III. Quarter (Sep 30 2022) year on year, to $0 million and declined by sequentially.


Rocket Pharmaceuticals Inc is Expected to report next financial results on February 27, 2023.

More on RCKT's Income Statement



Rocket Pharmaceuticals Inc 's in III. Quarter recorded net loss of $-57.756 million, an increase from net loss of $-50.118 million in III. Quarter a year ago.

Sequentially net loss advanced

More on RCKT's Growth

RCKT's Cash flow In III. Quarter company's net cash flow was $9 million, capital expenditures grew by -87.04%, to $-1 millions compare to same quarter a year ago and rose by -82.64% from II. Quarter (Jun 30 2022).

More on RCKT's Cash flow Statement


Rocket Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Rocket Pharmaceuticals Inc payed $ -2.31 cash per share, on a free-cash flow basis .